# Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF)

> **NCT01071746** · — · UNKNOWN · sponsor: **University College London Hospitals** · enrollment: 700 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01071746
- **Lead sponsor:** University College London Hospitals
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2010-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071746, "Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01071746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*